Treatment with tralokinumab improves health-related quality of life in adult patients with moderate to severe atopic dermatitis: results from a Phase 2b, randomised, double-blind, placebo-controlled study

SKIN The Journal of Cutaneous Medicine(2018)

引用 0|浏览0
暂无评分
摘要
Abstract not available. Disclosures: Study sponsored by LEO Pharma. Copyright 2018 SKIN
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要